|
TAF1D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.58199999953513E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.152000E-04 |
| Normal-vs-Stage2 |
3.876700E-03 |
| Normal-vs-Stage3 |
1.998530E-03 |
| Normal-vs-Stage4 |
2.162500E-03 |
| Stage1-vs-Stage2 |
2.037800E-01 |
| Stage1-vs-Stage3 |
4.708200E-01 |
| Stage1-vs-Stage4 |
2.234500E-02 |
| Stage2-vs-Stage3 |
6.589400E-01 |
| Stage2-vs-Stage4 |
5.730500E-02 |
| Stage3-vs-Stage4 |
1.320380E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.95869999961718E-07 |
| Normal-vs-AfricanAmerican |
1.410480E-04 |
| Normal-vs-Asian |
1.084050E-02 |
| Caucasian-vs-AfricanAmerican |
9.492800E-01 |
| Caucasian-vs-Asian |
7.489800E-01 |
| AfricanAmerican-vs-Asian |
7.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38639999999846E-05 |
| Normal-vs-Female |
4.12709999952909E-07 |
| Male-vs-Female |
1.716460E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.6895099999914E-05 |
| Normal-vs-Extreme_Weight |
7.832400E-04 |
| Normal-vs-Obese |
1.59348999999587E-05 |
| Normal-vs-Extreme_Obese |
2.707000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.697900E-02 |
| Normal_Weight-vs-Obese |
7.483400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.581040E-01 |
| Extreme_Weight-vs-Obese |
4.667700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.221800E-01 |
| Obese-vs-Extreme_Obese |
1.994630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.035700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.8744999996656E-07 |
| Normal-vs-Age(61-80Yrs) |
1.965260E-04 |
| Normal-vs-Age(81-100Yrs) |
4.932000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.397380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.600100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.885700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.483800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.403800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.041400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.64410000000182E-05 |
| Normal-VS-Type2 PRCC |
4.618600E-04 |
| Normal-VS-KIRP CIMP |
1.119750E-02 |
| Normal-VS-Unclassified PRCC |
2.323400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.252000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.678400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.512400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.272300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.805400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.773500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.796300E-04 |
| Normal-vs-N1 |
4.188100E-04 |
| Normal-vs-N2 |
4.962200E-03 |
| N0-vs-N1 |
3.265900E-02 |
| N0-vs-N2 |
4.597600E-01 |
| N1-vs-N2 |
6.018200E-01 |
|
|
